⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Johnson & Johnson announces TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to show significant improvement in spinal pain and stiffness in landmark axial psoriatic arthritis (PsA) study
prnewswire.com
JNJ
Single infusion of CARVYKTI®▼ (ciltacabtagene autoleucel) delivered five-year treatment-free remissions in 50% of patients in early line relapsed/refractory multiple myeloma
globenewswire.com
JNJ
Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered five-year treatment-free remissions in 50% of patients in early line relapsed/refractory multiple myeloma
prnewswire.com
JNJ
Global Autoimmune Treatment Market to Reach USD 321.95 Billion by 2034, Driven by Rising Prevalence of Autoimmune Diseases, Growing Adoption of Biologics, and Advances in Precision Medicine Says Maximize Market Research
prnewswire.com
ABBV
JNJ
AMGN
BMY
PFE
NVS
SNY
LLY
AZN
UCB
BIIB
VTRS
GILD
KYMR
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
prnewswire.com
NVS
BIIB
SNY
MRK
BMY
JNJ
TEVA
VTRS
AMGN
Laparoscopic Instruments Market worth $15.86 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
JNJ
STRL
CNMD
RAINN Names Simintha Esson Chief Development Officer
globenewswire.com
JNJ
AMZN
GOOG
Solenic Medical Appoints Daniel Hawkins as Chairman of the Board
globenewswire.com
ISRG
JNJ
Pharmaceutical Drug Delivery Market Forecasts Growth from $2.15T (2026) to $2.92T by 2031, Profiling J&J, Pfizer, Roche, BD & Novartis
globenewswire.com
JNJ
PFE
BDX
NVS
Oncology Clinical Trials Market Set for Strong Growth Through 2035, Fueled by Precision Medicine, Immunotherapy and Decentralized Trial Innovation
globenewswire.com
AZN
MRK
NVS
LRCX
NVDA
GOOG
MSFT
AMGN
BMY
JNJ
PFE
LLY
ABBV
IQV
ICLR
LH
TMO